Literature DB >> 9804160

Characterization of mutations located in exon 18 of the CFTR gene.

A Vankeerberghen1, L Wei, H Teng, M Jaspers, J J Cassiman, B Nilius, H Cuppens.   

Abstract

In order to get a better insight into the function of amino acid residues located in the second transmembrane domain of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, all exon 18 mutations found in cystic fibrosis (CF) patients were characterized at the protein and at the electrophysiological level. Of the different mutations present in transmembrane helix 12 (M1137V, M1137R, I11139V and deltaM1140), and the intracytoplasmic loop connecting TM12 and NBD2 (D1152H and D1154G), only M1137R interfered with the proper maturation of the protein. Permeability studies performed after injection of the different wild-type and mutant cRNAs in Xenopus laevis oocytes indicated that the mutations did not alter the permeability sequence of the CFTR channels. The whole cell cAMP activated chloride currents, however, were significantly reduced for M1137V, I1139V, D1152H and D1154G and close to zero for deltaM1140, indicating that these mutations interfere with the proper gating of the chloride channels.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9804160     DOI: 10.1016/s0014-5793(98)01042-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Conformational changes relevant to channel activity and folding within the first nucleotide binding domain of the cystic fibrosis transmembrane conductance regulator.

Authors:  Rhea P Hudson; P Andrew Chong; Irina I Protasevich; Robert Vernon; Efrat Noy; Hermann Bihler; Jian Li An; Ori Kalid; Inbal Sela-Culang; Martin Mense; Hanoch Senderowitz; Christie G Brouillette; Julie D Forman-Kay
Journal:  J Biol Chem       Date:  2012-06-21       Impact factor: 5.157

2.  Molecular determinants of anion selectivity in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  P Linsdell; A Evagelidis; J W Hanrahan
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

3.  Functional arrangement of the 12th transmembrane region in the CFTR chloride channel pore based on functional investigation of a cysteine-less CFTR variant.

Authors:  Feng Qian; Yassine El Hiani; Paul Linsdell
Journal:  Pflugers Arch       Date:  2011-07-28       Impact factor: 3.657

Review 4.  Cystic fibrosis transmembrane regulator protein mutations: 'class' opportunity for novel drug innovation.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Pamela L Zeitlin
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

5.  Mechanisms for rescue of correctable folding defects in CFTRDelta F508.

Authors:  Diane E Grove; Meredith F N Rosser; Hong Yu Ren; Anjaparavanda P Naren; Douglas M Cyr
Journal:  Mol Biol Cell       Date:  2009-07-22       Impact factor: 4.138

6.  Mutation-specific potency and efficacy of cystic fibrosis transmembrane conductance regulator chloride channel potentiators.

Authors:  Antonella Caputo; Alexandre Hinzpeter; Emanuela Caci; Nicoletta Pedemonte; Nicole Arous; Marco Di Duca; Olga Zegarra-Moran; Pascale Fanen; Luis J V Galietta
Journal:  J Pharmacol Exp Ther       Date:  2009-06-02       Impact factor: 4.030

7.  Novel residues lining the CFTR chloride channel pore identified by functional modification of introduced cysteines.

Authors:  Mohammad Fatehi; Paul Linsdell
Journal:  J Membr Biol       Date:  2009-04-19       Impact factor: 1.843

8.  Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.

Authors:  Sunil Sheth; Julie C Shea; Michele D Bishop; Sanjiv Chopra; Meredith M Regan; Emily Malmberg; Carolyn Walker; Ryan Ricci; Lap-Chee Tsui; Peter R Durie; Julian Zielenski; Steven D Freedman
Journal:  Hum Genet       Date:  2003-06-03       Impact factor: 4.132

9.  The cystic fibrosis transmembrane conductance regulator (CFTR): three-dimensional structure and localization of a channel gate.

Authors:  Mark F Rosenberg; Liam P O'Ryan; Guy Hughes; Zhefeng Zhao; Luba A Aleksandrov; John R Riordan; Robert C Ford
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.